Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

R2 Technology/CADx suits resolved

This article was originally published in The Gray Sheet

Executive Summary

Mammography computer-aided detection system makers agree to dismiss lawsuits against each other "without prejudice" Oct. 1. A September 2002 R2 suit against CADx over three of its patents was met with an October 2002 CADx countersuit citing three different patents. R2's recent patent settlement with iCAD included $2 mil., plus royalty payments (1"The Gray Sheet" Sept. 15, 2003, In Brief)...

You may also be interested in...



iCAD vs. R2

R2 ImageChecker mammography system infringes Scanis, Inc. '637 patent, July 1 suit filed by Scanis and iCAD, Inc. alleges. According to the suit, the Scanis technology dates back to 1989 when the company (then Sterometrix) created the first computer-aided detection system for breast cancer, four years before R2 was founded. According to R2, however, the '637 patent is invalid, and the iCAD/Scanis suit is merely a "diversionary tactic" intended to deflect attention from R2's October 2002 suit against iCAD, regarding three separate cancer detection patents...

Dr Reddy's Adds To OTC Portfolio With Glenmark Deal

Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.

Sandoz Launches US Awareness Campaign

Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel